• News
  • Finance

Daily Digest

Bio-Matrix Scientific Group announced its BioPharma Inc. unit has entered into a letter of intent to purchase patented intellectual property covering a novel means of treating breast cancer, and Cytori Therapeutics Inc. announced it has appointed Steven Kesten as executive vice president and chief medical officer, according to company announcements, SEC filings and Bloomberg News.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!